Publications

Hemmings HC, Greengard P.  1986.  DARPP-32, a dopamine-regulated phosphoprotein.. Prog Brain Res. 69:149-59.

Nairn AC, Hemmings HC, Walaas SI, Greengard P.  1988.  DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons.. J Neurochem. 50(1):257-62.

Hökfelt T, Foster G, Schultzberg M, Meister B, Schalling M, Goldstein M, Hemmings HC, Ouimet C, Greengard P.  1988.  DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus.. Adv Exp Med Biol. 235:65-82.

Matovcik LM, Hemmings HC, Kinder BK.  1995.  DARPP-32 (dopamine and cAMP-regulated phosphoprotein, M(r) 32,000) is a membrane protein in the bovine parathyroid.. FEBS Lett. 364(1):67-74.

Stone RA, Laties AM, Hemmings HC, Ouimet CC, Greengard P.  1986.  DARPP-32 in the ciliary epithelium of the eye: a neurotransmitter-regulated phosphoprotein of brain localizes to secretory cells.. J Histochem Cytochem. 34(11):1465-8.

OuYang W, Hemmings HC.  2005.  Depression by isoflurane of the action potential and underlying voltage-gated ion currents in isolated rat neurohypophysial nerve terminals.. J Pharmacol Exp Ther. 312(2):801-8.

Foster GA, Schultzberg M, Hökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P.  1987.  Development of a dopamine- and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation.. J Neurosci. 7(7):1994-2018.

Ratnakumari L, Vysotskaya TN, Duch DS, Hemmings HC.  2000.  Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels.. Anesthesiology. 92(2):529-41.

Zhou C, Johnson KW, Herold KF, Hemmings HC.  2019.  Differential Inhibition of Neuronal Sodium Channel Subtypes by the General Anesthetic Isoflurane.. J Pharmacol Exp Ther. 369(2):200-211.

Lingamaneni R, Hemmings HC.  2003.  Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABA(A) receptors.. Br J Anaesth. 90(2):199-211.

S Bullock A, Platholi J, Gjyrezi A, Heerdt PM, Tung HYLim, Hemmings HC.  2007.  Differential regulation of protein phosphatase-1(I) by neurabin.. Biochem Biophys Res Commun. 358(1):140-4.

Speigel IA, Patel K, Hemmings HC.  2022.  Distinct effects of volatile and intravenous anaesthetics on presynaptic calcium dynamics in mouse hippocampal GABAergic neurones.. Br J Anaesth. 128(6):1019-1028.

Ouyang W, Wang G, Hemmings HC.  2004.  Distinct rat neurohypophysial nerve terminal populations identified by size, electrophysiological properties and neuropeptide content.. Brain Res. 1024(1-2):203-11.

Absil P, Foidart A, Hemmings HC, Steinbusch HW, Ball GF, Balthazart J.  2001.  Distribution of DARPP-32 immunoreactive structures in the quail brain: anatomical relationship with dopamine and aromatase.. J Chem Neuroanat. 21(1):23-39.

Hemmings HC, Girault JA, Nairn AC, Bertuzzi G, Greengard P.  1992.  Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissues of various species: comparison with DARPP-32.. J Neurochem. 59(3):1053-61.

Herold KF, Andersen OS, Hemmings HC.  2017.  Divergent effects of anesthetics on lipid bilayer properties and sodium channel function.. Eur Biophys J. 46(7):617-626.

Hemmings HC, Antognini JF.  2006.  Do general anesthetics add up? Anesthesiology. 104(6):1120-2.

Meister B, Arvidsson U, Hemmings HC, Greengard P, Hökfelt T.  1991.  Dopamine- and adenosine-3':5'-monophosphate (cAMP)-regulated phosphoprotein of Mr 32,000 (DARPP-32) in the retina of cat, monkey and human.. Neurosci Lett. 131(1):66-70.

Meister B, Schultzberg M, Hemmings HC, Greengard P, Goldstein M, Hökfelt T.  1991.  Dopamine- and adenosine-3',5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization.. J Auton Nerv Syst. 36(1):75-84.

Meister B, Fryckstedt J, Schalling M, Cortés R, Hökfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P.  1989.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.. Proc Natl Acad Sci U S A. 86(20):8068-72.

Ouimet CC, Hemmings HC, Greengard P.  1988.  Dopamine-regulated protein phosphorylation in the basal ganglia.. Adv Exp Med Biol. 235:1-17.

Durstewitz D, Kröner S, Hemmings HC, Güntürkün O.  1998.  The dopaminergic innervation of the pigeon telencephalon: distribution of DARPP-32 and co-occurrence with glutamate decarboxylase and tyrosine hydroxylase.. Neuroscience. 83(3):763-79.

Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, Hemmings HC, Nairn AC, Greengard P.  2000.  Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.. Neuropharmacology. 39(9):1637-44.

Hemmings HC, Adamo AI.  1997.  Effect of halothane on conventional protein kinase C translocation and down-regulation in rat cerebrocortical synaptosomes.. Br J Anaesth. 78(2):189-96.

Lingamaneni R, Hemmings HC.  1999.  Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes.. Neurosci Lett. 276(2):127-30.